Navigation Links
Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Date:4/24/2008

CRANBURY, N.J., April 24 /PRNewswire-FirstCall/ -- Amicus Therapeutics Inc. (Nasdaq: FOLD), today announced that John F. Crowley, President and Chief Executive Officer, will present a corporate update at the Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, April 30, 2008, at 2:20 p.m. EDT, at the Ritz-Carlton in Key Biscayne, Florida.

The presentation will be webcast live and may be accessed by visiting Amicus' website at http://www.amicustherapeutics.com. A replay of the webcast will also be available on the Company's website for 30 days until May 30, 2008.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease. The Company recently completed Phase I clinical trials of AT2220 for the treatment of Pompe disease.

CONTACTS:

Investors: Media:

John Quirk Cory Tromblee

Porter Novelli Life Sciences Porter Novelli Life Sciences

(212) 601-8296 (617) 897-8294


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Contec’s Sporicidin disinfectant solut...grade disinfectants against H1N1 and Influenza A.,...) November 24, 2009 -- Contec Inc, the leading man...that their Sporicidin disinfectants have been de... A viruses, including Pandemic 2009 H1N1 influenza...
(Date:11/23/2009)...ov.23/PRNewswire/-InimexPharmaceuticals,Inc.announ...sPresidentandCEO. ,, Abramsbringsmorethan25year...eisaco-inventorofthenuclearmedicineimagingagent,Ca...lcwherehewasManager,BiomedicalResearchWorldwide.In...CandwasPresidentandCEOfrom1996to2006.AnorMEDdiscov...
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire/--PearlTherapeuticsInc.,a...ctsforthetreatmentofchronicrespiratorydiseases,tod...sBoardofDirectors.Mr.Rosenhas25yearsofexperiencein...ingkeyrolesatGileadSciencesandALZACorporation.Hisa...ardtosix. ,, "Howiebringsawealthofproductdevelo...
(Date:11/20/2009)..., , , , , , , ,...AUDIO: , A team of scientists from Washington...a, Cold Spring Harbor Laboratory and Iowa State Un...The... , , Click here for more in... , , , , , , , ...
Breaking Biology Technology:Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Inimex Announces Appointment of New CEO 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
...Pioneering medical device company Signostics annou...Food and Drug Administration (FDA) for its palm-si... (Photo: http://www.newscom.com/cgi-bin/prnh/2009...t-effective device that for the first time makes i...o use ultrasound in their clinical practice. Just ...
...otek,s Commitment to the Development of Farletuzum...nza,s Ability to Offer Specialty Development and M...Switzerland, May 19 Morphotek(R), Inc., a subsidi...za Group Ltd jointly announced today that they hav...upport the development and manufacturing of a subs...
...utic for IBD with Novel Mode of Action , , MOUNTA...ay announced that data from the company,s PROTECT-...ion in Crohn,s disease Trial) Phase II/III clinica...with moderate-to-severe Crohn,s disease will be pr...gestive Disease Week (DDW) meeting. Traficet-EN i...
Other Biology Technology:Signostics Receives FDA Clearance for World's Smallest Ultrasound Product 2Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 2Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 3Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 3ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 5
(Date:11/23/2009)..., University of Southern California biomedical eng... develop a new tool to help clinicians distinguish...rom chronic problems manageable with drugs and lif...eters inserted into the arteries feeding the heart...umen") of these blood vessels, often revealing dep...
(Date:11/23/2009)...A novel approach to classify the gender of six-wee...icks from being killed shortly after birth, accord...ity of Technology in Germany and his team. Their u...r of young birds shows that it is a fast and accur...eeding industry to identify and select female eggs...
(Date:11/23/2009)...Sewer overflows are a nasty business, posing dange...lina State University is launching a new project w... Agency (EPA) that targets the fat and grease that...nd will give urban planners new tools to further r...overflows from "sanitary" sewer systems, as oppose...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Rescuing male turkey chicks 2Lose the fat: Targeting grease to curtail sewer overflows 2Drink Up 21 SCAN Health Plan Quenches Thirst of Area Seniors With 1 000 Cases of Bottled Water From Community Water Drive 54445 1Drink Up 21 SCAN Health Plan Quenches Thirst of Area Seniors With 1 000 Cases of Bottled Water From Community Water Drive 54445 2Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48 Year Exemplary Record of Quality 54443 1Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48 Year Exemplary Record of Quality 54443 2New Guidelines Provide Clarity About Probiotics 54441 1New Guidelines Provide Clarity About Probiotics 54441 2
...chers at Albert Einstein College of Medicine of Ye... brain enzyme may play a role in preventing weight... Cell Metabolism . , To understand what drives hu... have focused on the hypothalamus, an almond-sized...rols body temperature, hunger, and thirst. Specia...
...iscover a new species, it would be in some remote,...w York. But a team from the Sackler Institute for ...ural History has done the unexpected. Looking at t...rs found that the groupgenetically speakingcompris...t only ends a long debate about the taxonomy of th...
...aten to lead to the break-up of the Wilkins Ice Sh...ce shelf available to the public via the ,Webcam, ...pments as they occur. , The Wilkins Ice Shelf, a ...ntarctic Peninsula, has undergone many changes in ...late November), newly formed rifts were discovered...
Other Biology News:Brain enzyme may play key role in controlling appetite and weight gain 2Dwarf crocodiles split into three species 2
...rotein is in solution or in a gel piece, we can id...roteins will be digested to produce a mixture of p...des are determined by MALDI-TOF, and the amino aci...LDI-TOF will be determined by MALDI-TOF/TOF. The m...
Factor Xa Protease from QIAGEN
...s for interferons are cytopathic effect inhibition...Sample types include; tissue culture supernatents;... In these assays, one unit is defined as the quant...e the cytopathic effect of viral infection by 50%....
...s for interferons are cytopathic effect inhibition...Sample types include; tissue culture supernatents;... In these assays, one unit is defined as the quant...e the cytopathic effect of viral infection by 50%....
Biology Products: